# Amelia Virtual Care

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amelia-virtual-care

- Industry: Healthcare IT
- Headquarters: Barcelona, Spain
- Website: www.ameliavirtualcare.com
- Total disclosed funding: $1.2M
- Latest round: Seed (Jun 3, 2015)
- Investors on record: 1

## About

Founded in 2014 and based in Barcelona, Spain, Psico Smart Apps, S.L. specializes in AI-driven virtual care solutions that enhance therapeutic workflows for healthcare professionals and patients, focusing on improved mental and physical health outcomes.Psico Smart Apps, S.L. provides AI-driven virtual care solutions aimed at optimizing therapeutic processes. Founded by Xavier Ripoll in 2014, the company operates from its headquarters in Barcelona, Spain. It has completed a total of 4 funding deals, with the most recent investment occurring in June 2022, raising EUR 7 million from investors including Asabys Partners, CG Health Ventures, Caixa Capital Risc, and others. The latest funding round was aimed at supporting the company's operational activities and clinical evidence initiatives.Psico Smart Apps focuses on creating AI-powered virtual care solutions tailored for healthcare professionals and their patients. Its product lineup includes platforms that support mental health therapies and rehabilitation processes, allowing for personalized treatment environments. These solutions are designed to cater to various healthcare settings, including hospitals and clinics, ensuring a broad reach across markets like the USA, Australia, Israel, Spain, and Europe. The company aims to facilitate effective therapeutic interventions through innovative technology.In 2021, Psico Smart Apps reported a revenue of EUR 1,529,402.70 while experiencing an EBITDA loss of EUR 3,180,704.50 for the same year. Their revenue model primarily consists of B2B transactions, with healthcare organizations subscribing to their services and solutions.Following the EUR 7 million funding raised in June 2022, Psico Smart Apps plans to enhance its team and expand its clinical evidence initiatives. The company is focusing on developing new products that will further integrate AI in therapeutic environments, aiming for market expansion in additional European countries by the end of 2023. These strategic initiatives are designed to solidify their presence in existing markets while exploring new opportunities in the healthcare sector.

## Funding rounds

- Seed, Jun 3, 2015, $1.1M — Rothenberg Ventures
- Seed, Jan 30, 2015, $0.1M — Rothenberg Ventures

## Investors

- Rothenberg Ventures (https://capitalatlas.ai/funds/rothenberg-ventures) — Seed